Moreover, levels of miR-26b are downregulated in the cartilage of osteoarthritis (OA) patients compared to those in controls [18], where decreased levels of miR-26b also have been suggested to contribute to disease progression by upregulation of the NF-κB signaling pathway. Here, NFKB1 is linked to osteoarthritis.